Helicobacter pylori InfectionHelicobacter pylori Infection
Prevalenza: ~50% of global population infected; higher in developing countries
Evidence-Ranked Ingredients
| Ingrediente | Grado | Studi | Direzione | |
|---|---|---|---|---|
| Lactobacillus gasseri | B | 3 | Positive | Visualizza → |
| N-Acetyl Cysteine (NAC) | C | 3 | Positive | Visualizza → |
About
A chronic bacterial infection of the gastric mucosa affecting approximately half the world's population. H. pylori colonizes the gastric epithelium, causes chronic inflammation, and is classified as a Group 1 carcinogen. Triple or quadruple antibiotic therapy is standard treatment; probiotics studied as adjunctive therapy.
Common Symptoms
Risk Factors
- Childhood acquisition
- Crowded living conditions
- Contaminated water
- Low socioeconomic status
- Lack of sanitation
Frequently Asked Questions
What supplements may help with Helicobacter pylori Infection?
How is the evidence for Helicobacter pylori Infection supplements graded?
How many studies on Helicobacter pylori Infection supplements have been reviewed?
What are common symptoms of Helicobacter pylori Infection?
Related Conditions
Condizioni che condividono ingredienti studiati
Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.